Meta-analysis of 3 randomised trial datasets (5 reports; 518 in ctDNA efficacy population): ctDNA-guided/stratified adjuvant immunotherapy vs observation or placebo after radical surgery for muscle-invasive urothelial carcinoma improved DFS (HR 0.46) and OS (HR 0.56).
Meta-analysisn = 518
Mirza et al. ctDNA-guided or ctDNA-stratified adjuvant immunotherapy compared with observation or placebo after radical surgery for muscle-invasive urothelial carcinoma: a GRADE-assessed systematic review and meta-analysis